Linagliptin CAS:668270-12-0 Faumea Faumea

Linagliptin (igoa fefa'ataua'iga Tradjenta ma Trajetna) ose inhibitor o le dipeptidyl peptidase-4 (DPP-4) na fa'amaonia e le US FDA ia Me 2011 mo togafitiga o le ma'isuka ituaiga 2 fa'atasi ai ma mea'ai ma fa'amalositino.Linagliptin (BI-1356) ua faʻamatalaina o se mea e sili ona filifilia, faʻagesegese le faʻaogaina ma le umi e galue ai le inhibitor DPP-4.Linagliptin na aliaʻe mai taumafaiga faʻapitoa o le xanthine-based DPP-4 inhibitors faʻatasi ai ma le taʻitaʻi muamua na iloa mai se faʻasalalauga HTS.

Poloaiga po'o Talosaga Fa'amatalaga

Fa'amatalaga Oloa

Faailoga o oloa

Fa'aoga ma A'afiaga

Linagliptin (TrajentaR, Tradjenta TM, Trazenta TM, Trayenta TM) o se faʻamalosi tautala, sili ona filifilia o le dipeptidyl peptidase-4 ma o le sui muamua o lana vasega e faʻaumatia tele e ala i se auala e le faʻaogaina.Linagliptin e faʻaalia mo le faʻaaogaina i aso taitasi mo le togafitia o tagata matutua e maua i le maʻisuka ituaiga 2. Linagliptin e galue e faʻaititia le kulukose toto e ala i le taofiofia o le enzyme DPP-4, ma puipuia ai le faʻaleagaina o hormones incretin (glucagon-like peptide-1 [GLP). -1] ma le peptide insulinotropic e faalagolago i le kulukose) ma le faʻaitiitia o femalagaiga o le kulukose pe a uma le 'ai.